Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS. (Lancet, 1998)
European Study Group on Interferon Β-1b in Secondary Progressive MS.